P. Collste

717 total citations
24 papers, 529 citations indexed

About

P. Collste is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Collste has authored 24 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 11 papers in Analytical Chemistry and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Collste's work include Analytical Methods in Pharmaceuticals (11 papers), Blood Pressure and Hypertension Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). P. Collste is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Blood Pressure and Hypertension Studies (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). P. Collste collaborates with scholars based in Sweden, United Kingdom and Netherlands. P. Collste's co-authors include K. Haglund, M. D. Rawlins, B. Edgar, F. Sj�qvist, B. Norlander, Marianne Frisk‐Holmberg, Lena Palmér, Leif Bertilsson, Christer von Bahr and C G Regårdh and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Drugs and British Journal of Clinical Pharmacology.

In The Last Decade

P. Collste

24 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Collste Sweden 16 141 135 124 104 95 24 529
A. Gérardin Switzerland 13 101 0.7× 99 0.7× 114 0.9× 79 0.8× 153 1.6× 25 630
DB Jack United Kingdom 15 105 0.7× 96 0.7× 152 1.2× 145 1.4× 153 1.6× 40 609
Ermelinda Sakmar United States 18 67 0.5× 121 0.9× 171 1.4× 141 1.4× 148 1.6× 40 909
R. E. Vestal United States 8 151 1.1× 71 0.5× 146 1.2× 108 1.0× 129 1.4× 12 607
Boo Edgar Sweden 11 129 0.9× 70 0.5× 195 1.6× 66 0.6× 116 1.2× 17 508
AJ Wood United States 11 95 0.7× 68 0.5× 177 1.4× 65 0.6× 87 0.9× 16 450
Ola Rönn Sweden 13 172 1.2× 54 0.4× 142 1.1× 83 0.8× 119 1.3× 25 545
H. L. Elliott United Kingdom 14 262 1.9× 65 0.5× 115 0.9× 124 1.2× 103 1.1× 42 683
DG Waller United Kingdom 17 109 0.8× 178 1.3× 241 1.9× 77 0.7× 137 1.4× 28 920
G. Bodem Germany 13 139 1.0× 53 0.4× 74 0.6× 61 0.6× 79 0.8× 47 463

Countries citing papers authored by P. Collste

Since Specialization
Citations

This map shows the geographic impact of P. Collste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Collste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Collste more than expected).

Fields of papers citing papers by P. Collste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Collste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Collste. The network helps show where P. Collste may publish in the future.

Co-authorship network of co-authors of P. Collste

This figure shows the co-authorship network connecting the top 25 collaborators of P. Collste. A scholar is included among the top collaborators of P. Collste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Collste. P. Collste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reg�rdh, C. G., B. Edgar, Rolf Olsson, et al.. (1989). Pharmacokinetics of felodipine in patients with liver disease. European Journal of Clinical Pharmacology. 36(5). 473–479. 46 indexed citations
2.
Edgar, B., P. Collste, K. Haglund, & C G Regårdh. (1987). Pharmacokinetics and Haemodynamics of Felodipine as Monotherapy in Hypertensive Patients. Drugs. 34(Supplement 3). 28–29. 6 indexed citations
3.
Edgar, B., P. Collste, K. Haglund, & C G Regårdh. (1987). Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients.. PubMed. 10(5). 388–94. 42 indexed citations
4.
Nordin, Conny, et al.. (1987). Effects of nortriptyline and its 10-hydroxy metabolite on plasma noradrenaline (NA) concentrations, heart rate and blood pressure during intravenous NA infusion.. PubMed. 9(10). 691–6. 4 indexed citations
5.
Collste, P., B Brismar, A Alveryd, et al.. (1986). The catecholamine concentration in central veins of hypertensive patients--an aid not without problems in locating phaeochromocytoma.. PubMed. 530. 67–71. 10 indexed citations
6.
Collste, P., K. Haglund, & Christer von Bahr. (1980). Plasma levels and effects of metoprolol after single and multiple oral doses. Clinical Pharmacology & Therapeutics. 27(4). 441–449. 16 indexed citations
7.
Haglund, K. & P. Collste. (1980). Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients. European Journal of Clinical Pharmacology. 17(5). 321–328. 6 indexed citations
8.
Collste, P., et al.. (1979). Contribution of 4‐hydroxy‐alprenolol to adrenergic beta receptor blockade of alprenolol. Clinical Pharmacology & Therapeutics. 25(4). 416–422. 17 indexed citations
9.
Collste, P., et al.. (1979). Influence of pentobarbital on effect and plasma levels of alprenolol and 4‐hydroxy‐alprenolol. Clinical Pharmacology & Therapeutics. 25(4). 423–427. 12 indexed citations
10.
Haglund, K., et al.. (1979). Influence of pentobarbital on metoprolol plasma levels. Clinical Pharmacology & Therapeutics. 26(3). 326–329. 12 indexed citations
11.
Collste, P. & Rolf Nordlander. (1979). Quinidine dosage, with special reference to an oral loading dose schedule.. British Journal of Clinical Pharmacology. 7(3). 293–297. 6 indexed citations
12.
Collste, P., K. Haglund, Marianne Frisk‐Holmberg, & M. D. Rawlins. (1976). Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. European Journal of Clinical Pharmacology. 10(2). 85–88. 15 indexed citations
13.
Collste, P., K. Haglund, Marianne Frisk‐Holmberg, et al.. (1976). Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. European Journal of Clinical Pharmacology. 10(2). 89–95. 22 indexed citations
14.
Collste, P., Mats Garle, M. D. Rawlins, & F. Sj�qvist. (1976). Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses. European Journal of Clinical Pharmacology. 9(4). 319–325. 30 indexed citations
15.
Collste, P., et al.. (1976). Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. Clinical Pharmacology & Therapeutics. 20(2). 130–137. 58 indexed citations
16.
Rawlins, M. D., P. Collste, Leif Bertilsson, & Lena Palmér. (1975). Distribution and elimination kinetics of carbamazepine in man. European Journal of Clinical Pharmacology. 8(2). 91–96. 65 indexed citations
17.
Rawlins, M. D., et al.. (1974). Steady-state plasma concentrations of alprenolol in man. European Journal of Clinical Pharmacology. 7(5). 353–356. 21 indexed citations
18.
Karlsson, Eva Nordberg, P. Collste, & M. D. Rawlins. (1974). Plasma levels of lidocaine during combined treatment with phenytoin and procainamide. European Journal of Clinical Pharmacology. 7(6). 455–459. 16 indexed citations
19.
Collste, P., et al.. (1973). ARRHYTHMIA PROPHYLAXIS WITH PROCAINE AMIDE: PLASMA CONCENTRATIONS IN RELATION TO DOSE. Acta Medica Scandinavica. 194(1-6). 405–411. 15 indexed citations
20.
Collste, P., Eva Nordberg Karlsson, B. Norlander, J Sievers, & Folke Sjöqvist. (1972). [Arrhythmia prophylaxis with procanamide: inadequate dosage?].. PubMed. 69. Suppl 2:47–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Gérardin Breakdown of academic impact, for papers by DB Jack Breakdown of academic impact, for papers by Ermelinda Sakmar Breakdown of academic impact, for papers by R. E. Vestal Breakdown of academic impact, for papers by Boo Edgar Breakdown of academic impact, for papers by AJ Wood Breakdown of academic impact, for papers by Ola Rönn Breakdown of academic impact, for papers by H. L. Elliott Breakdown of academic impact, for papers by DG Waller Breakdown of academic impact, for papers by G. Bodem
Rankless by CCL
2026